International Journal of Current Research in Physiology and Pharmacology <p><strong>eISSN: 2523-6709,&nbsp;</strong><strong>pISSN: 2523-6695.</strong></p> <p style="text-align: left;">(Logos are embedded with links)</p> <hr> <p style="text-align: left;"><a href=";refid=dcrecen" target="_blank" rel="noopener"><img src="/public/site/images/admin/base.png" alt=""></a> <a href=";publication=International+Journal+of+Clinical+and+Biomedical+Research&amp;publisher_str=Sumathi+Publications&amp;type=Journal+Article" target="_blank" rel="noopener"><img src="/public/site/images/admin/crossref1.png" alt=""></a> <a title="IJCRPP" href=";as_sdt=0%2C5&amp;;oq=site" target="_blank" rel="noopener"><img src="/public/site/images/admin/GoogleScholar1.png" alt=""></a> <a href=";qt=results_page" target="_blank" rel="noopener"><img src="/public/site/images/admin/logo_wcmasthead_en1.png" alt=""></a> <a href="" target="_blank" rel="noopener"><img src="/public/site/images/admin/pkp-index-301.png" alt=""></a> <a href=";la=en" target="_blank" rel="noopener"><img src="/public/site/images/admin/sherparomeo-home.jpg" alt=""></a></p> <hr> <p>International Journal of Current Research in Physiology and Pharmacology (IJCRPP) provides an outlet for research scientists in areas of Health Sciences. IJCRPP is open access, online &amp; Print, peer-reviewed international journal with a primary objective to provide research and applications related to Physiology, Pharmacology and Clinical Medicine.</p> <p>Submitted papers must be in technical English, suitable for scientific publication. All articles have to be original articles that have not been published elsewhere or are being considered for publication in other journals. All articles submitted will be peer-reviewed by experts. Receipt of the manuscript will be acknowledged by email. Every effort will be made to complete the review process within 3 weeks and communicated to the corresponding author. Papers should be submitted electronically on the journal's website. The Editorial Board will strive for the quality of the journal and will also index the journal in various indexing bodies and the information will be updated on the journal website from time to time.</p> <p>We welcome all your submissions.</p> <p>I hope you will consider IJCRPP for your next submission.</p> <p>If any further information is required please mail to: <a href="">Editor </a>or<a href=""> Journal Office</a>.</p> <p>The journal accepts manuscripts in the following forms:</p> <ul> <li class="show">Original research articles</li> <li class="show">Reviews</li> <li class="show">Case reports</li> <li class="show">Short communications</li> <li class="show">Letters to editor</li> <li class="show">Discussion papers</li> <li class="show">Clinical Experience</li> <li class="show">Clinicopathological correlation</li> <li class="show">Book reviews</li> <li class="show">"How to do it" type articles describing new methods or procedures.</li> </ul> <p>Aim :</p> <ul> <li class="show">Our goal is to stimulate new research ideas and foster practical application from the research findings. The journal publishes original research, review articles, case reports of such high quality as to attract contributions from the relevant international communities.</li> </ul> <p>Critical Objective:</p> <ol> <li class="show">To maintain the highest standards of editorial integrity</li> <li class="show">To improve health, health care, and health education, internationally by elevating the quality of medical care, disease prevention, and research</li> <li class="show">To publish original, important, well-documented, peer-reviewed articles on basic medical sciences subject topics</li> <li class="show">To provide doctors with continuing education in basic&nbsp; science to support clinical decisions</li> <li class="show">To enable physicians to remain informed in multiple areas of basic medical science, including developments In the field of health education.</li> <li class="show">To achieve the highest level of ethical medical journalism and to produce a publication that is timely, credible, and enjoyable to read.</li> </ol> <p>Kind Regards,</p> <p>IJCRPP Editorial Team.</p> Sumathi Publications en-US International Journal of Current Research in Physiology and Pharmacology 2523-6695 <p>The journal <strong>allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions</strong>.</p> <p>The submitted papers are assumed to contain no proprietary material unprotected by patent or patent application; responsibility for technical content and for protection of proprietary material rests solely with the author(s) and their organizations and is not the responsibility of the journal. The main (first/corresponding) author is responsible for ensuring that the article has been seen and approved by all the other authors. It is the responsibility of the author to obtain all necessary copyright release permissions for the use of any copyrighted materials in the manuscript prior to the submission.</p> <p><strong>What are my rights as an author?</strong><br>It is important to check the policy for the journal to which you are submitting or publishing to establish your rights as<br>Author. Journal's standard policies allow the following re-use rights:</p> <ul> <li class="show">The journal allows the author(s) to hold the copyright without restrictions.</li> <li class="show">The journal allows the author(s) to obtain publishing rights without restrictions.</li> <li class="show">You may do whatever you wish with the version of the article you submitted to the journal.</li> <li class="show">Once the article has been accepted for publication, you may post the accepted version of the article on your own personal website, your department's website or the repository of your institution without any restrictions.</li> <li class="show">You may not post the accepted version of the article in any repository other than those listed above (i.e. you may not deposit in the repository of another institution or a subject-matter repository) until 12 months after publication of the article in the journal.</li> <li class="show">You may use the published article for your own teaching needs or to supply on an individual basis to research colleagues, provided that such supply is not for commercial purposes.</li> </ul> Reproductive Health of Women: a comprehensive review <p>Full access to sexual and reproductive health is a fundamental human right. Women and girls around the world, especially those living in poverty, have little or no access to reproductive health and rights information and services. Discrimination, shame, restrictive laws and regulations, and long-standing traditions are just some of the existing barriers to sexual and reproductive health. There is evidence that these rights affect not only individual women, but also families, communities and economies, but progress has been slow. Women's lifestyles have evolved throughout history. Life used to be difficult for most women. Many women have had unwanted pregnancies. Childbirth used to be dangerous and often ended in the death of the mother. Most women have never suffered menopause or senility in the past because they did not live long enough. Reproductive health is an important aspect of an individual's overall development and well-being. It may be the result of positive parenting, which is essential in adolescence and lays the foundation for good health in adulthood and beyond reproductive age, in both men and women. Female reproductive life does not begin at puberty and end at menopause. Also, a man's reproductive lifespan doesn't end when he becomes less likely to have more children. It is present and essential at every stage of human development and maturity. Reproductive health needs vary by age and stage of life. However, there are long-term effects throughout life, with each stage having a significant impact on future well-being.</p> <p><strong>Keywords: </strong>Women health, adulthood, fertility, sexual health, menstruation.</p> Imran Gani Irfat Ara Mohd Altaf Dar Copyright (c) 2023 Imran Gani, Irfat Ara, Mohd Altaf Dar 2023-08-27 2023-08-27 To evaluate the impact of aspirin in prevention of coronary artery disease in superspeciality hospital Jalandhar Punjab, India <p><strong>Introduction:</strong> Coronary artery disease (CAD), a prevalent cardiovascular ailment, arises from the gradual accumulation of fatty deposits, cholesterol, and other substances within the coronary arteries – the blood vessels responsible for supplying oxygen and nutrients to the heart muscle. Aspirin plays a pivotal role in the management of Coronary Artery Disease (CAD) due to its antiplatelet properties. CAD often involves the formation of blood clots within narrowed coronary arteries, potentially leading to heart attacks. Aspirin, a blood-thinning medication, helps prevent clot formation by inhibiting the aggregation of platelets, which are blood cells involved in clotting. <strong>Objective: </strong>The objective of this study was to the impact of aspirin in prevention of coronary artery disease in superspeciality hospital Jalandhar Punjab, India. <strong>Methodology:</strong> The study was conducted in cardiac care unit at Nasa and Hub Superspeciality hospital Jalandhar Punjab and exclusively on patients who presented with any kind of cardiac disorder symptoms. This study was approved by the Ethics committee of Nasa And Hub Superspeciality Hospital. All the subjects have signed the informed consent form. In this study, 200 patients were recruited in NASA AND HUB SUPERSPECIALITY HOSPITAL Jalandhar Punjab from 8<sup>th</sup> june 2022 to 8<sup>th</sup> September 2022. <strong>Results and Discussion:</strong> . In this study population, there were significant differences between male and female concerning cardiovascular risk factors, so cigarette smoking is very prevalent in young group and limited for males. We observed that hypertension and diabetes are present at high level in women than men, and the percentage of hypertension and diabetes increase in both gender with age. In the present study, we examined a representative sample of visits to physicians in the <strong>Nasa And Hub </strong>Superspeciality Hospital by patients with coronary artery disease, with a focus on visits to cardiologists and primary care physicians by patients in whom aspirin was not contraindicated. <strong>Conclusion: </strong>Aspirin continues to be the mainstay of antiplatelet therapy in individuals with coronary artery disease (CAD) in this observational study. Patients at a high risk of developing CVD in the future may be advised to take aspirin, but the potential for adverse effects must be recognised in addition to the advantages. As a result of our study, it is imperative to reinforce the need for proper coronary artery disease (CAD) management in order to prevent further coronary artery complications.</p> <p><strong>Keywords: </strong>Coronary artery disease, aspirin, smoking, hypertension</p> Abrar Bashir Malik Mashooq Ahmad Mir Zulfkar Qadrie Copyright (c) 2023 Abrar Bashir Malik, Mashooq Ahmad Mir, Zulfkar Qadrie, MOHD ALTAF DAR 2023-08-27 2023-08-27